After dismal Q2 earnings, Cano Health is working with JPMorgan and Oppenheimer as it pursues strategic alternatives, according to Axios.
JPMorgan is advising Cano on a potential sale of the whole company, while Oppenheimer is advising on possible divestitures or breakups of the business, sources report.
Primary care-focused Cano laid off 700 employees — about 17% of its workforce — earlier this month. Read more.
